Transfusions with laboratory-grown red blood cells: a new development in science.

It is inevitable to anticipate the development of laboratory abilities and their involvement in clinical research in a fast-paced world. The RESTORE study is one such incident that has drawn the interest of various specialists. Red blood cells (RBCs) that have been generated in a laboratory have been transfused into a volunteer in this trial.

Unusual reaction to fluorescein dye in patients with inflammatory eye disease.

Purpose: Ocular side effects attributable to intravenous fluorescein dye are not well characterized. The purpose of this report was to describe three patients with an unusual ocular reaction after the intravenous administration of fluorescein dye.

Methods: Retrospective review of the clinical and photographic records of three patients.

Basiliximab plus low-dose cyclosporin vs. OKT3 for induction immunosuppression following renal transplantation.

Background: Current immunosuppressive therapies are very effective in preventing acute rejection (AR) and graft loss following renal transplantation. Newer agents now make it possible to develop equally efficacious but better tolerated and less toxic strategies. This is especially relevant for our ageing recipients.

The pharmacological evaluations of some N-[pyridyl-(phenyl)carbonylamino]hydroxypropyl-1,2,3,6-tetrahy dropyridi nes as potential antiinflammatory agents.

A few novel tetrahydropyridines like benzoylamino-4-hydroxypropyl-1,2,3,6-tetrahydropyridine (THP), 7a (Fig. 1) which had been previously synthesized in our laboratory were tested for their antiinflammatory and hypo/hyperglycemic activities. The tetrahydropyridines contained a hydroxypropyl group in either the 4 or 5 position of the THP ring.